Floatz logo

DIACETYL(N(4)-METHYLTHIOSEMICARBAZONATO) COPPER (II)

Amyotrophic Lateral Sclerosis

Collaborative Medicinal Development Pty LimitedSmall moleculePhase 2/3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
73/ 100

Competitive context

151 Active assets in the Amyotrophic Lateral Sclerosis cohort.

Asset / SponsorPhaseRating
TAURURSODIOL
Amylyx Pharmaceuticals Inc.
Phase 3BBB
Tofersen
Biogen
Phase 4BBB
Mexiletine
Bjorn Oskarsson, MD
Phase 4BB
Riluzole
AB Science
Phase 4BB
mt-1186
Tanabe Pharma Corporation
Phase 3BB

View all 50 →

Same molecule, other indications

DIACETYL(N(4)-METHYLTHIOSEMICARBAZONATO) COPPER (II) is also rated in:

Motor Neuron DiseaseDormant
CC
Indicative ·
46 / 100
View asset →
Parkinson diseaseDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →